(Q45088794)
Statements
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial (English)
Jens Overgaard
Marianne Nordsmark
Danish Head and Neck Cancer Study Group